Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. | J Exp Clin Cancer Res | 2019 | 31253192 | PubTator, text mining | PubMed |
| Genome-wide association study identifies loci for arterial stiffness index in 127,121 UK Biobank participants. | Sci Rep | 2019 | 31235810 | PubTator, text mining | PubMed |
| Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma. | iScience | 2019 | 31229894 | PubTator, text mining | PubMed |
| Discoidin domain receptors: Micro insights into macro assemblies. | Biochim Biophys Acta Mol Cell Res | 2019 | 31229648 | PubTator, text mining | PubMed |
| Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis. | Sci Adv | 2019 | 31223646 | PubTator, text mining | PubMed |
Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. | Oncotarget | 2019 | 31217907 | PubTator, text mining | PubMed |
| Glioma Stem Cell-Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling. | Cancer Discov | 2019 | 31201181 | PubTator, text mining | PubMed |
| Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC. | Cancer Metab | 2019 | 31164982 | PubTator, text mining | PubMed |
| Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl4-induced liver fibrosis in rats by RNA-sequencing. | Chem Biol Interact | 2019 | 31150632 | PubTator, text mining | PubMed |
| Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients. | BMC Med Genomics | 2019 | 31146747 | PubTator, text mining | PubMed |
| Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis. | Respir Res | 2019 | 31142317 | PubTator, text mining | PubMed |
| The Expanding Role of MT1-MMP in Cancer Progression. | Pharmaceuticals (Basel) | 2019 | 31137480 | PubTator, text mining | PubMed |
| Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor. | Sci Adv | 2019 | 31131319 | PubTator, text mining | PubMed |
| DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells. | Front Pharmacol | 2019 | 31130862 | PubTator, text mining | PubMed |
| Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. | Mol Cancer | 2019 | 31126310 | PubTator, text mining | PubMed |
| DDR1 (discoidin domain receptor tyrosine kinase 1) drives glioblastoma therapy resistance by modulating autophagy. | Autophagy | 2019 | 31117874 | PubTator, text mining | PubMed |
| Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma. | Mol Oncol | 2019 | 31116512 | PubTator, text mining | PubMed |
| Expression of DDR1 in the CNS and in myelinating oligodendrocytes. | Biochim Biophys Acta Mol Cell Res | 2019 | 31108116 | PubTator, text mining | PubMed |
| SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib. | Cancers (Basel) | 2019 | 31091806 | PubTator, text mining | PubMed |
| Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. | Nat Commun | 2019 | 31086186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=69